+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 3 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are collecting detailed information about patients with venous thromboembolism VTE to improve understanding of this condition, especially in groups often excluded from clinical trials such as pregnant women, elderly patients, and those with severe health issues. This observational registry aims to provide data that can help reduce death rates, recurrences of blood clots, bleeding problems, and arterial events related to VTE. This study gathers clinical details about each patient, including other health conditions, and tracks the type, dose, duration, and results of antithrombotic treatments over the first three months. The registry is accessible online to assist doctors in managing complex cases by comparing patient profiles and identifying those at higher risk of complications. Participants clinical status and treatment outcomes are recorded, focusing on recurrence of VTE, bleeding events, and mortality over a three-year period. The information supports the creation of predictive scores to help healthcare providers identify patients at higher risk. The study started in 2001 and plans to continue until 2027, with ongoing data collection and follow-up.

All AgesAll Genders
305 locations
I

Actively Recruiting

Researchers are evaluating an integrated home care program called ADMIT for older adults aged 70 or more who live at home and face complex health and social needs. The study aims to see if this multi-component intervention, which uses technology and coordinated care, can increase the percentage of days these individuals spend at home compared to usual care. Additional goals include reducing health crises, improving quality of life for patients and their caregivers, and assessing the programs cost-effectiveness and overall experience. Participants will be randomly assigned to either receive usual care or the ADMIT program, which is co-created by professionals, patients, and caregivers. The ADMIT program involves proactive candidate detection from health and social services, assignment of reference professionals from both sectors, shared diagnosis and individualized care plans, and ongoing shared follow-up. A technological platform supports communication and information sharing among all parties, with optional use of sensors and robotic devices to assist home care. During the six-month intervention, researchers will track the percentage of days participants spend at home, monitor health and social crises, and gather feedback on experiences from patients, caregivers, and professionals. The study uses mixed methods to evaluate effectiveness, safety, and cost-utility in real-world settings, with an overall goal to support aging individuals in their homes while improving care quality and system sustainability.

Age: 70Years +All GendersPhase Not Applicable
8 locations
A

Actively Recruiting

Researchers are investigating how changes in urinary sodium and chloride levels relate to fluid overload and short-term outcomes in patients hospitalized with acute heart failure AHF. The study aims to determine if these changes reflect how effectively excess fluid is removed during hospital stays and whether they are linked to congestion at discharge and the risk of worsening heart failure or death afterward. This prospective, multicenter observational study plans to enroll at least 223 patients with AHF treated with intravenous diuretics. Participants hospitalized for AHF and receiving intravenous diuretics as part of their usual care will undergo multiple clinical assessments, blood and urine tests, and echocardiographic evaluations during their hospital stay. Researchers will collect biochemical and echocardiographic data, including biomarkers such as NT-proBNP, CA125, sST2, bioADM, and CD146. Clinical events like worsening heart failure and all-cause mortality will be tracked at 30 days and 3 months after discharge. Decongestion will be assessed using clinical evaluations, echographic parameters, and estimated plasma volume status. Throughout the study, participants will have repeated tests and assessments during hospitalization to monitor fluid status and heart function. Researchers will measure residual congestion 72 hours after admission and follow participants for clinical outcomes for up to three months after discharge. The study focuses on evaluating how urinary sodium and chloride dynamics relate to patient outcomes in AHF without interfering with standard treatments, lasting from hospital admission through three months post-discharge.

Age: 18Years +All Genders
4 locations